A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Clinical trial NCT05154487 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05154487
- Sponsor
- GOG Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2028-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.